Index by author

May 01, 2007; Volume 74,Issue 5

  1. Herts, Brian R.

    1. Intravenous iodinated contrast agents: Risks and problematic situations
      Kimmie L. Bui, MD, Joseph D. Horner, DO, Brian R. Herts, MD and David M. Einstein, MD
      Cleveland Clinic Journal of Medicine May 2007, 74 (5) 361-367;

      Many diagnostic imaging studies use intravenous contrast media. Although these agents are generally safe, they do pose some risk of adverse reactions.

  2. Horner, Joseph D.

    1. Intravenous iodinated contrast agents: Risks and problematic situations
      Kimmie L. Bui, MD, Joseph D. Horner, DO, Brian R. Herts, MD and David M. Einstein, MD
      Cleveland Clinic Journal of Medicine May 2007, 74 (5) 361-367;

      Many diagnostic imaging studies use intravenous contrast media. Although these agents are generally safe, they do pose some risk of adverse reactions.

  3. Malone, Donald

    1. Anabolic steroid abuse: Psychiatric and physical costs
      Farid Talih, MD, Omar Fattal, MD and Donald Malone, MD
      Cleveland Clinic Journal of Medicine May 2007, 74 (5) 341-352;

      Anabolic-androgenic steroid abuse is no longer confined to professional athletes. Physicians should be aware of its signs and symptoms so that they can address its adverse effects and treat it.

  4. Mandell, Brian F.

    1. Old drug, new data, continued vigilance
      Brian F. Mandell, MD, PhD
      Cleveland Clinic Journal of Medicine May 2007, 74 (5) 309;

      Colchicine, an old and familiar drug for gout, has found another use in preventing and treating pericarditis. But familiarity should not dampen vigilance.

  5. Masimasi, Nziavake

    1. Newer hormonal therapies: Lower doses; oral, transdermal, and vaginal formulations
      Mala S. Sivanandy, MD, Nziavake Masimasi, MD and Holly L. Thacker, MD
      Cleveland Clinic Journal of Medicine May 2007, 74 (5) 369-375;

      We review some of the hormonal regimens that have been approved in the past 5 years.

  6. Sabharwal, Vivek

    1. Neurologic effects of hyponatremia and its treatment
      Peter Widdess-Walsh, MB, Vivek Sabharwal, MD, Sevag Demirjian, MD and Michael DeGeorgia, MD
      Cleveland Clinic Journal of Medicine May 2007, 74 (5) 377-383;

      Twenty-one days after surviving a hemorrhagic stroke, the patient develops new neurologic symptoms. A computed tomographic scan shows new cerebral edema. Her serum sodium concentration is 121 mmol/L.

  7. Saltzman, Heath

    1. Should all patients with acute pericarditis be treated with colchicine?
      Heath Saltzman, MD and Howard H. Weitz, MD
      Cleveland Clinic Journal of Medicine May 2007, 74 (5) 385-386;

      Colchicine should be considered a first-line treatment for acute pericarditis and for preventing recurrent episodes.

  8. Sivanandy, Mala S.

    1. Newer hormonal therapies: Lower doses; oral, transdermal, and vaginal formulations
      Mala S. Sivanandy, MD, Nziavake Masimasi, MD and Holly L. Thacker, MD
      Cleveland Clinic Journal of Medicine May 2007, 74 (5) 369-375;

      We review some of the hormonal regimens that have been approved in the past 5 years.

  9. Stoller, James K.

    1. Neurologic effects of hyponatremia and its treatment
      Peter Widdess-Walsh, MB, Vivek Sabharwal, MD, Sevag Demirjian, MD and Michael DeGeorgia, MD
      Cleveland Clinic Journal of Medicine May 2007, 74 (5) 377-383;

      Twenty-one days after surviving a hemorrhagic stroke, the patient develops new neurologic symptoms. A computed tomographic scan shows new cerebral edema. Her serum sodium concentration is 121 mmol/L.

  10. Talih, Farid

    1. Anabolic steroid abuse: Psychiatric and physical costs
      Farid Talih, MD, Omar Fattal, MD and Donald Malone, MD
      Cleveland Clinic Journal of Medicine May 2007, 74 (5) 341-352;

      Anabolic-androgenic steroid abuse is no longer confined to professional athletes. Physicians should be aware of its signs and symptoms so that they can address its adverse effects and treat it.

« Previous (Pages : 1 2 3 ... 3) Next »
Back to top

In this issue